{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:31:43Z","timestamp":1786609903426,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd012024.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000}}],"reference-count":189,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012024.pub3","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T03:57:37Z","timestamp":1574222257000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy"],"prefix":"10.1002","volume":"2025","author":[{"given":"Jodie M","family":"Dodd","sequence":"additional","affiliation":[{"name":"School of Paediatrics and Reproductive Health, Discipline of Obstetrics and Gynaecology; The University of Adelaide, Women's and Children's Hospital; Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie M","family":"Grivell","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology ; Flinders University and Flinders Medical Centre; Bedford Park Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia M","family":"OBrien","sequence":"additional","affiliation":[{"name":"Women's and Babies Division, Discipline of Obstetrics and Gynaecology; Robinson Research Institute, The University of Adelaide; North Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Dowswell","sequence":"additional","affiliation":[{"name":"C\/o Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health; The University of Liverpool ; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R","family":"Deussen","sequence":"additional","affiliation":[{"name":"Adelaide Medical School, Robinson Research Institute; The University of Adelaide; North Adelaide Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/uog.11284","article-title":"The use of vaginal natural progesterone for prevention of preterm birth in IVF\/ICSI pregnancies","volume":"40","author":"Aboulghar","year":"2012","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.rbmo.2012.03.013","article-title":"The use of vaginal natural progesterone for prevention of preterm birth in IVF\/ICSI pregnancies","volume":"25","author":"Aboulghar","year":"2012","journal-title":"Reproductive BioMedicine Online"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1471-0528.13031","article-title":"A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity","volume":"122","author":"Awwad","year":"2015","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0004|cit4","unstructured":"Prevention of preterm delivery in twin pregnancies by 17 alpha hydroxyprogesterone caproate clinicaltrials.gov\/ct2\/show\/NCT00141908"},{"issue":"S1","key":"10.1002\/14651858.CD012024.pub3-BIB0005|cit5","first-page":"307","article-title":"Incidence of GDM in twin pregnancies of women receiving prophylactic 17-A OH progesterone caproate","volume":"23","author":"Nassar","year":"2010","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/j.ajog.2009.10.671","article-title":"Women with prolonged premature rupture of the membrane do not benefit from weekly progesterone: a randomized clinical trial","volume":"201","author":"Briery","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD012024.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SMJ.0b013e3181afee12","article-title":"Progesterone does not prevent preterm births in women with twins","volume":"102","author":"Briery","year":"2009","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Agra IK Brizot ML Miyadahira MY Carvalho MH Francisco RP Zugaib M The effect of prenatally administered vaginal progesterone on uterine artery doppler in asymptomatic twin pregnancies European Journal of Obstetrics & Gynecology, and Reproductive Biology 2016 205 11 4","DOI":"10.1016\/j.ejogrb.2016.08.016"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"82.e1","DOI":"10.1016\/j.ajog.2015.02.021","article-title":"Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study","volume":"213","author":"Brizot","year":"2015","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/aogs.12843","article-title":"Prenatal administration of vaginal progesterone and frequency of uterine contractions in asymptomatic twin pregnancies","volume":"95","author":"De Oliveira","year":"2016","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD012024.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/AOG.0b013e318193c677","article-title":"Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial","volume":"113","author":"Caritis","year":"2009","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-009-1351-2","article-title":"Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial","volume":"283","author":"Cetingoz","year":"2011","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"248.e1","DOI":"10.1016\/j.ajog.2010.06.016","article-title":"Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial","volume":"203","author":"Combs","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0014|cit14","first-page":"S168","article-title":"17-hydroxyprogesterone for triplet pregnancy does not reduce prematurity or neonatal morbidity, may increase midtrimester loss","volume":"201","author":"Combs","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0015|cit15","unstructured":"17OHP for reduction of neonatal morbidity due to preterm birth (PTB) in twin and triplet pregnancies clinicaltrials.gov\/ct2\/show\/NCT00163020"},{"issue":"12","key":"10.1002\/14651858.CD012024.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1055\/s-0034-1370342","article-title":"Fetal fibronectin versus cervical length as predictors of preterm birth in twin pregnancy with or without 17-hydroxyprogesterone caproate","volume":"31","author":"Combs","year":"2014","journal-title":"American Journal of Perinatology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2010.12.042","article-title":"17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial","volume":"204","author":"Combs","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/j.ajog.2012.10.640","article-title":"Fetal fibronectin and cervical length as predictors of preterm birth in twin pregnancies, with or without 17-hydroxyprogesterone caproate","volume":"208","author":"Combs","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1016\/j.ajog.2011.10.484","article-title":"17-hydroxyprogesterone caproate for women with history of preterm birth in a prior pregnancy and twins in the current pregnancy","volume":"206","author":"Combs","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ajog.2010.10.018","article-title":"17-hydroxyprogesterone for twin pregnancy: no reduction in prematurity or neonatal morbidity","volume":"204","author":"Combs","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0021|cit21","first-page":"S98","article-title":"The impact of maternal weight upon the effectiveness of 17-hydroxyprogesterone in preventing preterm birth among twin gestations","volume":"206","author":"Heitmann","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/j.ajog.2008.09.720","article-title":"17-alpha hydroxyprogesterone caproate does not increase the risk of gestational diabetes in singleton and twin pregnancies","volume":"199","author":"Horton","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0023|cit23","unstructured":"Vaginal progesterone to prevent early preterm birth in twin pregnancy with short cervix. Double blind, placebo-controlled, randomized clinical trial clinicaltrials.gov\/ct2\/show\/NCT01812239"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0024|cit24","first-page":"692","article-title":"Inefficacy of 17alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy","volume":"56","author":"Hartikainen-Sorri","year":"1980","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0025|cit25","unstructured":"Hartikainen-Sorri AL Kauppila A Tuimala R Management of twin pregnancy with 17 alpha- hydroxyprogesterone caproate [abstract] 9th World Congress of Gynecology and Obstetrics; 1979 October 26-31; Tokyo, Japan 1979 298 9"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0026|cit26","unstructured":"17-alpha hydroxyprogesterone in multiple pregnancies to prevent handicapped infants isrctn.com\/ISRCTN40512715"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2393-7-7","article-title":"Progesterone for the prevention of preterm birth in women with multiple pregnancies: the AMPHIA trial","volume":"7","author":"Lim","year":"2007","journal-title":"BMC Pregnancy & Childbirth"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","article-title":"17alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trial","volume":"118","author":"Lim","year":"2011","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/uog.11174","article-title":"Effect of 17-alpha hydroxyprogesterone caproate on cervical length in twin pregnancies","volume":"40","author":"Lim","year":"2012","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0030|cit30","first-page":"282A","article-title":"Is second trimester cervical length a predictor for an effect of 17-alpha hydroxyprogesterone caproate on neonatal morbidity in multiple pregnancies? Results from the AMPHIA trial (ISRCTN40512715)","volume":"17","author":"Lim","year":"2010","journal-title":"Reproductive Sciences"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0031|cit31","first-page":"282A","article-title":"The effect of 17-alpha hydroxyprogesterone caproate on cervical length in multiple pregnancies","volume":"17","author":"Lim","year":"2010","journal-title":"Reproductive Sciences"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/uog.12486","article-title":"Does 17-alpha-hydroxyprogesterone caproate affect fetal biometry and birth weight in twin pregnancy?","volume":"42","author":"Mulder","year":"2013","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0033|cit33","first-page":"S54","article-title":"Mid-pregnancy cervical length as a predictor of preterm birth in multiple pregnancies","volume":"204","author":"Willekes","year":"2011","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S0266462310000036","article-title":"Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis","volume":"26","author":"Eddama","year":"2010","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0035|cit35","unstructured":"Double blind randomised placebo controlled study of progesterone for the prevention of preterm birth in twins (STOPPIT) (ongoing trial) www.isrctn.com\/ISRCTN35782581"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"e0122341","DOI":"10.1371\/journal.pone.0122341","article-title":"STOPPIT baby follow-up study: the effect of prophylactic progesterone in twin pregnancy on childhood outcome","volume":"10","author":"McNamara","year":"2015","journal-title":"Plos One"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0037|cit37","first-page":"Fa8","article-title":"A randomized, double-masked, placebo-controlled study of progesterone for the prevention of preterm birth of twins (STOPPIT)","volume":"94","author":"Norman","year":"2009","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"9680","key":"10.1002\/14651858.CD012024.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0140-6736(09)60947-8","article-title":"Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis","volume":"373","author":"Norman","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1933719110395404","article-title":"Effect of prolonged in vivo administration of progesterone in pregnancy on myometrial gene expression, peripheral blood leukocyte activation, and circulating steroid hormone levels","volume":"18","author":"Norman","year":"2011","journal-title":"Reproductive Sciences"},{"issue":"S1","key":"10.1002\/14651858.CD012024.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/uog.9123","article-title":"Vaginal progesterone and the risk of preterm delivery in high-risk twin gestations - secondary analysis of a placebo-controlled randomized trial","volume":"38","author":"Klein","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/uog.9092","article-title":"Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis","volume":"38","author":"Klein","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/AOG.0b013e31825bc3cd","article-title":"Cytokines and the risk of preterm delivery in twin pregnancies","volume":"120","author":"Rode","year":"2012","journal-title":"Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/uog.9095","article-title":"Prevention of preterm delivery in twin gestations (PREDICT): a multicentre randomised placebo-controlled trial on the effect of vaginal micronised progesterone","volume":"38","author":"Rode","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/uog.9093","article-title":"Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone","volume":"38","author":"Rode","year":"2011","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/uog.15948","article-title":"Long-term effects of prenatal progesterone exposure: Neurophysiological development and hospital admissions in twins up to 8 years of age","volume":"48","author":"Vedel","year":"2016","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ajog.2006.10.003","article-title":"A randomized controlled trial of 17-hydroxyprogesterone caproate (17-OHPC) for the prevention of preterm birth in twins","volume":"195","author":"Caritis","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0047|cit47","unstructured":"Caritis SN Simhan H Relationship of 17-alpha hydroxyprogesterone caproate (17-OHPC) concentrations and gestational age at delivery in twins 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 139"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.ajog.2012.08.001","article-title":"Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation","volume":"207","author":"Caritis","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0049|cit49","unstructured":"Caritis SN Venkat R Impact of body mass index (BMI) on plasma concentrations of 17-alpha hydroxyprogesterone caproate (17-OHPC) 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 138"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ajog.2008.09.047","article-title":"The impact of cervical length on risk of preterm birth in twin gestations","volume":"199","author":"Durnwald","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"12","key":"10.1002\/14651858.CD012024.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3109\/14767051003702786","article-title":"Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17- hydroxyprogesterone caproate","volume":"23","author":"Durnwald","year":"2010","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"392.e1","DOI":"10.1016\/j.ajog.2009.06.036","article-title":"The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies","volume":"201","author":"Gyamfi","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD012024.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0030-1248940","article-title":"Neonatal outcomes in twin pregnancies delivered moderately preterm, late preterm, and term","volume":"27","author":"Refuerzo","year":"2010","journal-title":"American Journal of Perinatology"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0055|cit55","unstructured":"Simhan HN Caritis SN The effect of 17-alpha hydroxyprogesterone caproate (17-OHPC) on maternal plasma CRP levels in twin pregnancies 55th Annual Meeting of the Society of Gynecologic Investigation; 2008 March 26-29; San Diego, USA 2008 Abstract no: 140"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2012.10.177","article-title":"Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial","volume":"208","author":"Senat","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"194.e1","DOI":"10.1016\/j.ajog.2013.01.032","article-title":"Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial","volume":"208","author":"Senat","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"S2","key":"10.1002\/14651858.CD012024.pub3-BIB0058|cit58","first-page":"14","article-title":"Prevention of preterm delivery in asymptomatic women with twin pregnancy by 17 alpha-Hydroxyprogesterone caproate: a randomised controlled trial","volume":"25","author":"Senat","year":"2012","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0059|cit59","unstructured":"Natural progesterone and preterm birth in twins clinicaltrials.gov\/ct2\/show\/NCT00480402"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1471-0528.2012.03448.x","article-title":"Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial","volume":"120","author":"Serra","year":"2013","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0061|cit61","unstructured":"Vaginal progesterone versus placebo in multiple pregnancy clinicaltrials.gov\/ct2\/show\/NCT00343265"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0062|cit62","first-page":"S47","article-title":"Pilot randomized controlled trial of vaginal progesterone to prevent preterm birth in multiple pregnancy","volume":"29","author":"Swaby","year":"2007","journal-title":"JOGC: Journal of Obstetrics and Gynaecology Canada"},{"issue":"6","key":"10.1002\/14651858.CD012024.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1515\/jpm-2012-0057","article-title":"Vaginal progesterone to prevent preterm birth in multiple pregnancy: A randomized controlled trial","volume":"40","author":"Wood","year":"2012","journal-title":"Journal of Perinatal Medicine"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0064|cit64","first-page":"73A","article-title":"Relationship between cervical-vaginal fluid elafin concentrations and subsequent cervical shortening in women at high risk of spontaneous preterm birth","volume":"19","author":"Abbott","year":"2012","journal-title":"Reproductive Sciences"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0065|cit65","unstructured":"Evaluating the effectiveness of a cervical pessary to improve neonatal outcome by preventing preterm birth in women with a twin pregnancy and a short cervix anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12616000875404"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0066|cit66","first-page":"151","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labor. randomized controlled trial","volume":"21","author":"Borna","year":"2008","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/j.1879-3479.1979.tb00469.x","article-title":"A comparative study of the efficiency of hydroxyprogesterone caproate and of chlormadinone acetate in the prevention of premature labor","volume":"16","author":"Breart","year":"1979","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0002-9378(16)35945-2","article-title":"Effect of medroxyprogesterone acetate upon the duration and characteristics of human gestation and labor","volume":"83","author":"Brenner","year":"1962","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0069|cit69","first-page":"189A","article-title":"Serum progesterone concentrations in women with a previous preterm birth treated with vaginal progesterone supplementation","volume":"19","author":"Chandiramani","year":"2012","journal-title":"Reproductive Sciences"},{"issue":"22","key":"10.1002\/14651858.CD012024.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0071|cit71","unstructured":"First trimester progesterone therapy in women with a history of unexplained recurrent miscarriages: a randomised double-blind placebo-controlled multi-centre trial (The PROMISE [PROgesterone in recurrent MIScarriagE] Trial) isrctn.com\/ISRCTN92644181"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00404-015-3767-1","article-title":"Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety","volume":"293","author":"El-Refaie","year":"2016","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ajog.2006.10.012","article-title":"17 alpha hydroxy-progesterone caproate (17P) treatment reduced cervical shortening inhibiting cervical interleukin-1 secretion","volume":"195","author":"Facchinetti","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/j.ajog.2012.10.698","article-title":"Short cervix and activity restriction","volume":"208","author":"Grobman","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0075|cit75","first-page":"151A","article-title":"The role of 17-OHPC in preventing recurrent preterm birth in a current twin gestation","volume":"22","author":"Gyamfi-Bannerman","year":"2015","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9378(83)91051-7","article-title":"The effect of 17alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population","volume":"146","author":"Hauth","year":"1983","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0077|cit77","first-page":"205","volume-title":"Prevention of Preterm Birth","volume":"138","author":"Hobel","year":"1986"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0078|cit78","first-page":"112","article-title":"West Los Angeles premature prevention program: significant impact","volume":"15","author":"Hobel","year":"1987","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0002-9378(12)91479-9","article-title":"West Los Angeles preterm birth prevention project (LAPPP): program impact","volume":"166","author":"Hobel","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0080|cit80","first-page":"54","article-title":"The West Los Angeles preterm birth prevention project: I. program impact on high-risk women","volume":"170","author":"Hobel","year":"1994","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0081|cit81","first-page":"Abstract no. 00","article-title":"Randomized trial of cerclage and progesterone to prevent spontaneous preterm birth in high-risk women with a short cervix","volume":"39 Suppl","author":"Ionescu","year":"2012","journal-title":"Journal of Perinatal Medicine"},{"issue":"14","key":"10.1002\/14651858.CD012024.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0083|cit83","first-page":"30","article-title":"Habitual abortion. A controlled clinical study of progestational therapy","volume":"72","author":"LeVine","year":"1964","journal-title":"Western Journal of Surgery, Obstetrics, and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.ajog.2008.09.059","article-title":"The relationship between polymorphisms in the human progesterone receptor and clinical response to 17 alpha-hydroxyprogesterone caproate for the prevention of recurrent spontaneous preterm birth","volume":"199","author":"Manuck","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"S143, Abstract","DOI":"10.1016\/j.ajog.2015.10.281","article-title":"The effect of BMI on changes in salivary progesterone and estriol concentrations in pregnant patients receiving 17 a-hydroxyprogesterone caproate versus placebo","volume":"214","author":"Mardy","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"S378","DOI":"10.1016\/j.ajog.2013.10.803","article-title":"Prevention of preterm delivery with vaginal progesterone in women with arrested preterm labor: secondary analysis of the 4P trial","volume":"210","author":"Martinez de Tejada","year":"2014","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0087|cit87","unstructured":"Vaginal progesterone to prevent preterm delivery in women with preterm labor clinicaltrials.gov\/show\/NCT00536003"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/uog.13331","article-title":"Re-analysis of PREGNANT trial confirms that vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix","volume":"43","author":"McKay","year":"2014","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0089|cit89","first-page":"271A","article-title":"Effect of conception type on pregnancy outcomes in twin gestations","volume":"23","author":"Meints","year":"2016","journal-title":"Reproductive Sciences"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"S288, Abstract","DOI":"10.1016\/j.ajog.2015.10.577","article-title":"The effect of partial compliance on the prevention of recurrent preterm birth in women receiving weekly 17 alphahydroxyprogesterone caproate injections","volume":"214","author":"Haidar","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"S220, Abstract","DOI":"10.1016\/j.ajog.2015.10.442","article-title":"Smoking and preterm birth: A novel effect of 17 alphahydroxyprogesterone caproate (17OHP-C)","volume":"214","author":"Heyborne","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.ajog.2006.10.490","article-title":"Impact of 17alpha hydroxyprogesterone caproate administration on salivary progesterone and estriol [abstract]","volume":"195","author":"Klebanoff","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"506.e1","DOI":"10.1016\/j.ajog.2008.03.003","article-title":"Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo","volume":"199","author":"Klebanoff","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ajog.2005.10.173","article-title":"Does gestational age at randomization affect the efficacy of alpha hydroxyprogesterone caproate (17-OHCP) in preventing recurrent preterm delivery? [abstract]","volume":"193","author":"Koontz","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.ajog.2003.10.396","article-title":"More than one previous preterm delivery and the risk of preterm birth in women treated with 17 alpha-hydroxyprogesterone (17P) [abstract]","volume":"189","author":"Meis","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.AOG.0000174582.79364.a7","article-title":"Does progesterone treatment influence risk factors for recurrent preterm delivery?","volume":"106","author":"Meis","year":"2005","journal-title":"Obstetrics & Gynecology"},{"issue":"6 Pt 2","key":"10.1002\/14651858.CD012024.pub3-BIB0097|cit97","first-page":"S54","article-title":"17 alphahydroxyprogesterone caproate prevents recurrent preterm birth [abstract]","volume":"187","author":"Meis","year":"2002","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ajog.2006.10.017","article-title":"4-year follow-up of children exposed to 17alpha hydroxyprogesterone caproate (17P) in utero","volume":"195","author":"Northen","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstetrics & Gynecology"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD012024.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ajog.2005.06.036","article-title":"Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery","volume":"193","author":"Sibai","year":"2005","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.ajog.2004.10.295","article-title":"Plasma CRH levels at 16-20 weeks do not predict preterm delivery in women at high-risk for preterm delivery [abstract]","volume":"191","author":"Sibai","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0102|cit102","first-page":"Fa71","article-title":"Progesterone for prevention of preterm birth and improvement in pregnancy outcomes among primiparae of advanced maternal age","volume":"93","author":"Moghtadaei","year":"2008","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0103|cit103","first-page":"122","article-title":"Progesterone for prevention of preterm birth and improvement pregnancy outcomes among primiparae of advanced maternal age","volume":"21","author":"Moghtadei","year":"2008","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0104|cit104","unstructured":"Trial of progesterone in twins and triplets to prevent preterm birth clinicaltrials.gov\/ct2\/show\/NCT00099164"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0105|cit105","unstructured":"Progesterone vaginal pessary for prevention of preterm twin birth clinicaltrials.gov\/ct2\/show\/NCT02350231"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0106|cit106","unstructured":"The effectiveness of cervical pessary versus vaginal progesterone for preventing premature birth in IVF twin pregnancies: a randomized controlled trial clinicaltrials.gov\/ct2\/show\/record\/NCT02623881"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0107|cit107","first-page":"S200, Abstract","article-title":"Is there a racial disparity of progesterone to prevent preterm birth","volume":"197","author":"Defranco","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.ajog.2008.09.496","article-title":"Natural progesterone administration and the risk of medical complications of pregnancy: secondary analysis from a multinational, randomized, double blind, placebo-controlled trial","volume":"199","author":"O'Brien","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.ajog.2008.09.128","article-title":"Do other elements of the obstetrical history provide a possible indication for progesterone supplementation? Secondary analysis from the progesterone vaginal gel trial","volume":"199","author":"O'Brien","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1002\/14651858.CD012024.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/uog.7338","article-title":"Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial","volume":"34","author":"O'Brien","year":"2009","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/j.ajog.2011.10.508","article-title":"Two year infant outcomes for children exposed to supplemental intravaginal progesterone gel in utero: secondary analysis of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"206","author":"O'Brien","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ajog.2004.09.058","article-title":"Progesterone for prevention of recurrent preterm birth: impact of gestational age at prior delivery [abstract]","volume":"191","author":"Spong","year":"2004","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ajog.2012.10.191","article-title":"Vaginal progesterone as maintenance after an episode of preterm labor (PROMISE Study): a randomized, double blinded, placebo-controlled trial","volume":"208","author":"Palacio","year":"2013","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0114|cit114","unstructured":"Papiernik E Double blind study of an agent to prevent preterm delivery among women at increased risk Edition Schering, Serie IV, fiche 3. 1970 65 8"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0115|cit115","unstructured":"Rozenberg P Efficacy of 17 alpha-hydroxyprogesterones caproate for the prevention of preterm delivery Current Controlled Trials (www.controlled-trials.com\/) (accessed 5 October 2007) 2007"},{"issue":"6 Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.ajog.2006.10.375","article-title":"A randomized trial of cerclage versus 17-hydroxyprogesterone (17p) for the treatment of short cervix [abstract]","volume":"195","author":"Rust","year":"2006","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"10","key":"10.1002\/14651858.CD012024.pub3-BIB0117|cit117","first-page":"538","article-title":"Prevention of pre-term labour with progesterone","volume":"69","author":"Suvonnakote","year":"1986","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0002-9378(66)90173-6","article-title":"Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy","volume":"95","author":"Turner","year":"1966","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/14767050500246243","article-title":"Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial","volume":"18","author":"Walch","year":"2005","journal-title":"Journal of Maternal-Fetal & Neonatal Medicine"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"S288, Abstract","DOI":"10.1016\/j.ajog.2015.10.578","article-title":"Does the rate of preterm delivery in twin pregnancies differ by body mass index in women exposed to 17 alphahydroxyprogesterone?","volume":"214","author":"Do","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012024.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1016\/j.ajog.2015.10.671","article-title":"Effectiveness of intramuscular progesterone for the prevention of preterm birth in twin pregnancies based on body mass index","volume":"214","author":"Do","year":"2016","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/uog.8106","article-title":"Effect of prophylactic progesterone on incidence of preterm labour in spontaneous twin pregnancy, randomized controlled study","volume":"36","author":"Elsheikhah","year":"2010","journal-title":"Ultrasound in Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0124|cit124","unstructured":"Preterm delivery prevention in twins with progesterone clinicaltrials.gov\/ct2\/show\/NCT01927029"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0125|cit125","unstructured":"Evaluation of the role of vaginal progesterone in prevention of preterm labor in twin gestation with short cervix: randomised controlled trial clinicaltrials.gov\/ct2\/show\/record\/NCT02697331"},{"issue":"S1","key":"10.1002\/14651858.CD012024.pub3-BIB0126|cit126","first-page":"305","article-title":"Treatment with different types of progesterone in prevention of preterm delivery","volume":"23","author":"Ndoni","year":"2010","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0127|cit127","first-page":"28","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in preterm delivery prevention","volume":"14","author":"Saghafi","year":"2011","journal-title":"Iranian Journal of Obstetrics, Gynecology and Infertility"},{"issue":"10","key":"10.1002\/14651858.CD012024.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1447-0756.2011.01524.x","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in prevention of preterm delivery","volume":"37","author":"Saghafi","year":"2011","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012024.pub3-BIB0129|cit129","first-page":"A29","article-title":"POPPI: prevention of problems of preterm birth with progesterone in women at increased risk: a multicentre randomised controlled trial [abstract]","volume":"43","author":"Armson","year":"2007","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD012024.pub3-BIB0130|cit130","first-page":"40","article-title":"Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome: The PROGRESS trial","volume":"49","author":"Crowther","year":"2013","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"6","key":"10.1002\/14651858.CD012024.pub3-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2393-9-6","article-title":"Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial","volume":"9","author":"Dodd","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0132|cit132","unstructured":"Australasian collaborative trial of vaginal progesterone therapy isrctn.com\/ISRCTN20269066"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0133|cit133","unstructured":"Prevention of preterm birth in twin pregnancies - \u201cRandomised trial of progesterone versus placebo\u201d isrctn.com\/ISRCTN66445401"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0134|cit134","unstructured":"Comparing a double dose of vaginal progesterone to no treatment for the prevention of preterm birth in twins pregnancy and short cervix clinicaltrials.gov\/ct2\/show\/NCT02329535"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0135|cit135","unstructured":"A randomized trial of pessary and progesterone for preterm prevention in twin gestation with a short cervix clinicaltrials.gov\/ct2\/show\/NCT02518594"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0136|cit136","doi-asserted-by":"crossref","unstructured":"Agra IK Brizot ML Miyadahira MY Carvalho MH Francisco RP Zugaib M The effect of prenatally administered vaginal progesterone on uterine artery doppler in asymptomatic twin pregnancies European Journal of Obstetrics, Gynecology, and Reproductive Biology 2016 205 11 4","DOI":"10.1016\/j.ejogrb.2016.08.016"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0137|cit137","volume-title":"Australia's Mothers and Babies 2000","author":"Australian I of H and","year":"2003"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0138|cit138","volume-title":"Australia's Health 2014","year":"2014"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0301-2115(02)00422-0","article-title":"The involvement of progesterone in the onset of human labour","volume":"108","author":"Astle","year":"2003","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10 Suppl 1","author":"Blencowe","year":"2013","journal-title":"Reproductive Health"},{"issue":"6","key":"10.1002\/14651858.CD012024.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/0002-9378(84)90674-4","article-title":"Preterm delivery is not predicted by serial plasma estradiol or progesterone concentration measurements","volume":"150","author":"Block","year":"1984","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/GCO.0b013e32834551cd","article-title":"Preterm deliveries that result from multiple pregnancies associated with assisted reproductive technologies in the USA: a cost analysis","volume":"23","author":"Bromer","year":"2011","journal-title":"Current Opinion in Obstetrics & Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"398.e1","DOI":"10.1016\/j.ajog.2012.08.015","article-title":"Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation","volume":"207","author":"Caritis","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1472-6483(10)62251-1","article-title":"Global epidemiology of multiple birth","volume":"15 Suppl 3","author":"Collins","year":"2007","journal-title":"Reproductive Biomedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/1471-0528.13779","article-title":"17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis","volume":"123","author":"Combs","year":"2016","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"16","key":"10.1002\/14651858.CD012024.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.1633616100","article-title":"A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition","volume":"100","author":"Condon","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"Da Fonseca","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00404-021-06152-1.","article-title":"Retraction Note: Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety. 2021 Oct;304(4):1113.","volume":"304","author":"El-Refaie","journal-title":"Arch Gynecol Obstet."},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1440-1754.1999.00308.x","article-title":"Hospital admissions in the first year of life in very preterm infants","volume":"35","author":"Elder","year":"1999","journal-title":"Journal of Paediatrics and Child Health"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1053\/j.semperi.2014.08.013","article-title":"Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations","volume":"48","author":"Feghali","year":"2014","journal-title":"Seminars in Perinatology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1471-0528.2004.00059.x","article-title":"How should randomised trials including multiple pregnancies be analysed?","volume":"111","author":"Gates","year":"2004","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"6675","key":"10.1002\/14651858.CD012024.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/33176","article-title":"Inhibition of oxytocin receptor function by direct binding of progesterone","volume":"392","author":"Grazzini","year":"1998","journal-title":"Nature"},{"issue":"24","key":"10.1002\/14651858.CD012024.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMe030081","article-title":"Progesterone and preterm delivery - deja vu all over again","volume":"348","author":"Greene","year":"2003","journal-title":"New England Medical Journal"},{"issue":"1 Suppl E","key":"10.1002\/14651858.CD012024.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1542\/peds.103.SE1.319","article-title":"Consideration of the use of health status, functional outcome, and quality-of-life to monitor neonatal intensive care practice","volume":"103","author":"Hack","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0002-9378(97)70570-2","article-title":"Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys","volume":"176","author":"Haluska","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0156|cit156","first-page":"125","article-title":"Progesterone receptor localisation and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: evidence for functional progesterone withdrawal at parturition","volume":"9","author":"Haluska","year":"2002","journal-title":"Journal of the Society for Gynecological Investigation"},{"issue":"8","key":"10.1002\/14651858.CD012024.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ijc.29235","article-title":"Maternal use of fertility drugs and risk of cancer in children--a nationwide population-based cohort study in Denmark","volume":"136","author":"Hargreave","year":"2015","journal-title":"International Journal of Cancer"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0158|cit158","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1742-4755-10-S1-S1","article-title":"Born too soon: preterm birth matters","volume":"10 Suppl 1","author":"Howson","year":"2013","journal-title":"Reproductive Health"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1067\/mob.2003.194","article-title":"Supplemental progesterone to prevent preterm birth","volume":"188","author":"Iams","year":"2003","journal-title":"American Journal Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0161|cit161","first-page":"30","article-title":"Habitual abortion. A controlled clinical study of progestational therapy","volume":"72","author":"Le Vine","year":"1964","journal-title":"Western Journal of Surgical Obstetrics and Gynecology"},{"issue":"Suppl 20","key":"10.1002\/14651858.CD012024.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1471-0528.2003.00023.x","article-title":"Mechanism of labour - biochemical aspects","volume":"110","author":"Lopez-Bernal","year":"2003","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0163|cit163","unstructured":"Martin JA Hamilton BE Osterman MJK Births: Final data for 2013 National Vital Statistics Reports 2015 64 1 1 30"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-publhealth-090810-182459","article-title":"Prematurity: an overview and public health implications","volume":"32","author":"McCormick","year":"2011","journal-title":"Annual Review of Public Health"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"e0122341","DOI":"10.1371\/journal.pone.0122341","article-title":"STOPPIT Baby Follow-up Study: the effect of prophylactic progesterone in twin pregnancy on childhood outcome","volume":"10","author":"McNamara","year":"2015","journal-title":"PloS One"},{"issue":"24","key":"10.1002\/14651858.CD012024.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420270109","article-title":"Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations","volume":"27","author":"Michaelis","year":"1983","journal-title":"Teratology"},{"issue":"9","key":"10.1002\/14651858.CD012024.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/molehr\/7.9.875","article-title":"Interactions between progesterone receptor isoforms in myometrial cells in human labour","volume":"7","author":"Peiber","year":"2001","journal-title":"Molecular Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0169|cit169","first-page":"608","article-title":"Actions of placental and fetal adrenal steroid hormones in primate pregnancy","volume":"16","author":"Pepe","year":"1995","journal-title":"Endocrine Review"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0029-7844(94)00341-A","article-title":"Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis","volume":"85","author":"Raman-Wilms","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"514\u20139","DOI":"10.1016\/S0015-0282(16)48490-6","article-title":"Congenital malformations among offspring exposed in utero to progestins, Olmsted County, Minnesota, 1936\u20131974","volume":"43","author":"Resseguie","year":"1985","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0172|cit172","unstructured":"Review Manager 5 (RevMan 5) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012024.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/uog.17397","article-title":"Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data","volume":"49","author":"Romero","year":"2017","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/tera.1420220302","article-title":"Congenital abnormalities and hormones","volume":"22","author":"Schardein","year":"1980","journal-title":"Teratology"},{"issue":"1-2","key":"10.1002\/14651858.CD012024.pub3-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Schindler","year":"2008","journal-title":"Maturitas"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1471-0528.13032","article-title":"Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis","volume":"122","author":"Schuit","year":"2015","journal-title":"BJOG: an international journal of obstetrics and gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD012024.pub3-BIB0178|cit178","first-page":"252","article-title":"Predictive value of uterine contractility and the serum levels of progesterone and oestrogens with regard to preterm labour","volume":"18","author":"Smit","year":"1984","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"e004514","DOI":"10.1136\/bmjopen-2013-004514","article-title":"Trends in the incidence and mortality of multiple births by socioeconomic deprivation and maternal age in England: population-based cohort study","volume":"4","author":"Smith","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocrine Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-3016.1992.tb00769.x","article-title":"Survival and cerebral palsy in low birthweight infants: implications for perinatal care","volume":"6","author":"Stanley","year":"1992","journal-title":"Paediatric and Perinatal Epidemiology"},{"key":"10.1002\/14651858.CD012024.pub3-BIB0182|cit182","unstructured":"Stewart LA Tierney JF Cochrane Individual Patient Data Meta-analysis Methods Group Chapter 18: Reviews of individual patient data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012024.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.2013.285063","article-title":"How to use a subgroup analysis: users' guide to the medical literature","volume":"311","author":"Sun","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012024.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/ajo.12048","article-title":"Multiple deliveries: the reduced impact of in vitro fertilisation in Australia","volume":"53","author":"Umstad","year":"2013","journal-title":"Australian & New Zealand Journal of Obstetrics & Gynaecology"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0020-7292(82)90039-X","article-title":"Evaluation of the use of Proluton-Depot (hydroxyprogesterone hexanoate) in early pregnancy","volume":"20","author":"Varma","year":"1882","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD012024.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/uog.15948","article-title":"Long-term effects of prenatal progesterone exposure: neurophysiological development and hospital admissions in twins up to 8\u2009years of age","volume":"48","author":"Vedel","year":"2016","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials","volume":"266","author":"Yusuf","year":"1991","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD012024.pub3-BIB0188|cit188","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004947.pub3","article-title":"Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth","author":"Dodd","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012024.pub3-BIB0189|cit189","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012024","article-title":"Prenatal administration of progestogens for preventing preterm birth in women with a multiple pregnancy","author":"Dodd","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012024.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:18:23Z","timestamp":1786609103000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012024.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":189,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012024.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]}}}